Literature DB >> 3608271

Bilateral aseptic necrosis of the lunate in systemic sclerosis.

B Agus.   

Abstract

A case of scleroderma with severe Raynaud's phenomenon and vasculitis is presented, in whom bilateral aseptic necrosis of the lunate bones developed. To my knowledge, this is the first such case in the literature.

Entities:  

Mesh:

Year:  1987        PMID: 3608271

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Osteonecrosis in Churg-Strauss allergic vasculitis.

Authors:  S E Gusis; P Milozzi; J A Maldonado Cocco
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

Review 2.  Avascular necrosis in systemic sclerosis patients: a case-based review of demographics, presentation, and management.

Authors:  Bikash Basyal; Binita Bhandari; Chris T Derk
Journal:  Clin Rheumatol       Date:  2020-07-09       Impact factor: 2.980

3.  Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.

Authors:  Javier Alberto Cavallasca; Hugo Armando Laborde; Mariela Beatriz Araujo; Gustavo Guillermo Nasswetter
Journal:  Clin Rheumatol       Date:  2005-01-20       Impact factor: 2.980

4.  Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases.

Authors:  E Taccari; A Spadaro; V Riccieri; M A Grandilli; A Zoppini
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

5.  Kienbock's disease and juvenile idiopathic arthritis.

Authors:  Nicholas M Desy; Mitchell Bernstein; Edward J Harvey; Hazel Hazel
Journal:  Mcgill J Med       Date:  2011-06

6.  Low-field magnetic resonance imaging study on carpal arthritis in systemic sclerosis--low-grade erosive arthritis of carpal bones is an unexpected and frequent disease manifestation.

Authors:  Elif Akbayrak; Robert Dinser; Ulf Müller-Ladner; Ingo H Tarner
Journal:  Arthritis Res Ther       Date:  2013-01-04       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.